Trial intelligence / Profile preview

Calcium dobesilate for retinal microcirculation and function in diabetic retinopathy

ChiCTR1900026328Phase 4Recruiting

Sponsor
Department of Ophthalmology, Guangdong Provincial People's Hospital
Start
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in diabetic retinopathy (DR) comparing Calcium dobesilate with Placebo (2 arms). Primary endpoints: Retinal vessel density and Retinal function. Started Oct 2019; status: recruiting.

02

Drugs

calcium dobesilate
03

Conditions

diabetic retinopathy (DR)

Beyond the preview

Go deeper on ChiCTR1900026328.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900026328.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call